Search - tctmd.com

Displaying 1 - 20 of 28

Sort: Relevancy | Date

Presentation TCT 2025

Elevated Gradients Early After TAVR: HALT or PPM? Diagnosis and Management

Presenter: Amr E. Abbas

October 28, 2025

Presentation TCT 2025

TCT 228: Automatic detection and grading analysis of hypoattenuated leaflet thickening (HALT) after TAVR using artificial intelligence based imaging evaluation method

Presenter: Dejing Feng

October 25, 2025

Presentation NY Valves 2025

Thrombosis and HALT in TTVR: Knowns, Unknowns, and Clinical Implications

Presenter: Robin Le Ruz

June 26, 2025

Presentation NY Valves 2025

Management of HALT After TAVR: Anticoagulation, Which Agent, How Long

Presenter: George D. Dangas

June 26, 2025

Presentation NY Valves 2024

Histopathology From Explanted Valves in Patients With HALT and RLM

Presenter: Stephanie Sellers

June 07, 2024

Presentation NY Valves 2024

Halt is Not Relevant

Presenter: Stephan Windecker

June 06, 2024

Presentation NY Valves 2024

Halt is Relevant

Presenter: Raj Makkar

June 06, 2024

Presentation NY Valves 2024

Decrease in EOA as a Marker of Early HALT Detection Post Aortic Valve Replacement

Presenter: Pedro Covas

June 06, 2024

Presentation TCT 2023

Leaflet Thrombosis and HALT: The Achilles Heel of TTVR?

Presenter: Rahul Sharma

October 26, 2023

Presentation TCT 2023

TCT 732: Bridging Morphology and Flow: Exploring Their interplay in HALT Progression fFllowing TAVR Through CFD Analysis

Presenter: Thangam Natarajan

October 24, 2023

Presentation TCT 2023

TCT 588: Association of Prosthesis Deformation of Balloon-Expandable Transcatheter Aortic Valves With Subclinical Leaflet Thrombosis

Presenter: Shubhadarshini Pawar

October 24, 2023

Presentation TCT 2023

TCT 492: A Data-Driven Bayesian Model To Predict Leaflet Thrombosis After Bioprosthetic Aortic Valve Replacement

Presenter: Yousef Darestani

October 24, 2023

Presentation TCT 2023

TCT 258: Personalized, CT-guided Antithrombotic Therapy Versus Lifelong Single Antiplatelet Therapy to Reduce Thromboembolic and Bleeding Events in Non-atrial Patients After Transcatheter Aortic Valve Implantation

Presenter: Daniel Overduin

October 24, 2023

Presentation SCCT 2023

HALT – from Diagnosis to Prognosis

Presenter: Omar Khalique

July 28, 2023

Presentation TVT 2023

The Case for ‘Default OAC’ in Valve-in-Valve TAVR – Pros and Cons

Presenter: Isaac George

June 08, 2023

Presentation TVT 2023

Case Resolution: A Patient With Recent TAVR, Receiving SAPT, and at 1 Month Has Elevated Gradient on Echo, and CT Shows HALT – Now What

Presenter: Sachin Goel

June 08, 2023

Presentation TVT 2023

SPOTLIGHT LECTURE: Show Me the Data! Is HALT After TAVR Associated With Clinical Events or Accelerated SVD?

Presenter: Raj Makkar

June 08, 2023

Presentation TVT 2023

Prevention of and Antithrombotic Management for HALT and THV Thrombosis

Presenter: Tarun Chakravarty

June 08, 2023

Presentation TVT 2023

Diagnosis, and Imaging Findings in HALT and THV Thrombosis (Workup of Elevated Gradients)

Presenter: Joao Cavalcante

June 08, 2023

Presentation TVT 2023

Case Presentation: A Patient With Recent TAVR, Receiving SAPT, and at 1 Month Has Elevated Gradient on Echo, and CT Shows HALT – Now What?

Presenter: Sachin Goel

June 08, 2023

Advertisement

Elevated Gradients Early After TAVR: HALT or PPM? Diagnosis and Management

TCT 228: Automatic detection and grading analysis of hypoattenuated leaflet thickening (HALT) after TAVR using artificial intelligence based imaging evaluation method

Thrombosis and HALT in TTVR: Knowns, Unknowns, and Clinical Implications

Management of HALT After TAVR: Anticoagulation, Which Agent, How Long

Histopathology From Explanted Valves in Patients With HALT and RLM

Halt is Not Relevant

Halt is Relevant

Decrease in EOA as a Marker of Early HALT Detection Post Aortic Valve Replacement

Leaflet Thrombosis and HALT: The Achilles Heel of TTVR?

TCT 732: Bridging Morphology and Flow: Exploring Their interplay in HALT Progression fFllowing TAVR Through CFD Analysis

TCT 588: Association of Prosthesis Deformation of Balloon-Expandable Transcatheter Aortic Valves With Subclinical Leaflet Thrombosis

TCT 492: A Data-Driven Bayesian Model To Predict Leaflet Thrombosis After Bioprosthetic Aortic Valve Replacement

TCT 258: Personalized, CT-guided Antithrombotic Therapy Versus Lifelong Single Antiplatelet Therapy to Reduce Thromboembolic and Bleeding Events in Non-atrial Patients After Transcatheter Aortic Valve Implantation

HALT – from Diagnosis to Prognosis

The Case for ‘Default OAC’ in Valve-in-Valve TAVR – Pros and Cons

Case Resolution: A Patient With Recent TAVR, Receiving SAPT, and at 1 Month Has Elevated Gradient on Echo, and CT Shows HALT – Now What

SPOTLIGHT LECTURE: Show Me the Data! Is HALT After TAVR Associated With Clinical Events or Accelerated SVD?

Prevention of and Antithrombotic Management for HALT and THV Thrombosis

Diagnosis, and Imaging Findings in HALT and THV Thrombosis (Workup of Elevated Gradients)

Case Presentation: A Patient With Recent TAVR, Receiving SAPT, and at 1 Month Has Elevated Gradient on Echo, and CT Shows HALT – Now What?

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content